IMMUNEERING CORP - CLASS A (IMRX)

US45254E1073 - Common Stock

2.2  +0.2 (+10%)

Premarket: 2.19 -0.01 (-0.45%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
2.31M
20.31%
2.08M
-9.96%
320K
-84.62%

-100.00%
25.551M57.582M
125.36%
86.52M
50.26%
200.08M
131.25%
323.55M
61.71%
EBITDA
YoY % growth
-17.06M
-171.66%
-33.84M
-98.36%
-51.46M
-52.07%
-59.355M
-12.83%
-66.202M
-14.02%
-77.556M
-17.15%
-87.717M
-13.10%
-133.518M
-52.21%
-145.248M
-8.79%
-149.532M
-2.95%
-102M
31.79%
2.448M
102.40%
EBIT
YoY % growth
-17.08M
-171.11%
-33.89M
-98.42%
-51.74M
-52.67%
-58.458M
-12.90%
-66.662M
-14.12%
-89.834M
-34.76%
-105.618M
-17.57%
-104.773M
0.80%
-91.434M
12.73%
-128.024M
-40.02%
-51.926M
59.44%
32.802M
163.17%
Operating Margin
-739.39%-1,629.33%-16,168.75%N/AN/AN/AN/A-410.05%-158.79%-147.97%-25.95%10.14%
EPS
YoY % growth
N/AN/A-1.92
43.61%
-1.88
1.56%
-1.93
-2.03%
-1.71
11.38%
-2.09
-22.10%
-1.63
21.91%
-1.29
21.13%
-1.05
18.25%
-0.11
89.32%
0.62
650.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.52
-0.63%
-0.31
37.55%
-0.31
34.89%
-0.31
37.55%
-0.31
41.52%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-18.934M
-16.14%
-19.183M
-7.30%
-20.305M
-19.41%
-21.733M
-20.95%
-26.017M
-37.41%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.49
-13.95%
-0.560.0712.88%
Q2 2024
Q2Q % growth
-0.47
-9.30%
-0.530.0610.82%
Q1 2024
Q2Q % growth
-0.49
3.92%
-0.510.024.47%
Q4 2023
Q2Q % growth
-0.52
-4.00%
-0.48-0.04-9.09%
Q3 2023
Q2Q % growth
-0.43
12.24%
-0.500.0714.62%
Q2 2023
Q2Q % growth
-0.43
2.27%
-0.540.1120.08%
Q1 2023
Q2Q % growth
-0.51
-4.08%
-0.570.0610.71%
Q4 2022
Q2Q % growth
-0.50
-19.05%
-0.590.0914.85%
Q3 2022
Q2Q % growth
-0.49
-4.26%
-0.500.011.63%
Q2 2022
Q2Q % growth
-0.44
72.67%
-0.530.0917.27%
Q1 2022
Q2Q % growth
-0.49 -0.46-0.03-6.75%
Q4 2021
Q2Q % growth
-0.42 -0.40-0.02-5.04%
Q3 2021
Q2Q % growth
-0.47 -0.580.1119.16%
Q2 2021
Q2Q % growth
-1.61 -1.47-0.14-9.61%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth

-100.00%
%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
10.2K-10.2K-100.00%
Q4 2022
Q2Q % growth

-100.00%
61.2K-61.2K-100.00%
Q3 2022
Q2Q % growth
40K
-91.67%
155.377K-115.377K-74.26%
Q2 2022
Q2Q % growth
90K
-86.36%
180.877K-90.877K-50.24%
Q1 2022
Q2Q % growth
180K
-76.00%
234.6K-54.6K-23.27%
Q4 2021
Q2Q % growth
190K
-91.78%
571.883K-381.883K-66.78%
Q3 2021
Q2Q % growth
480K 663K-183K-27.60%
Q2 2021
Q2Q % growth
660K
37.50%
382.5K277.5K72.55%
Q1 2021
Q2Q % growth
750K
56.25%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% -0.25% -0.02%
RevenueN/A N/A N/A N/A